Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited
Contract Categories:
Business Finance
›
Modification Agreements
Summary
Boston Therapeutics Inc. and CJY Holdings Limited have agreed to amend their Securities Purchase Agreement dated September 24, 2015. The amendment increases the offering amount from $1,450,000 to $1,602,000 and clarifies that the note will convert automatically into a future preferred stock financing of up to $1,602,000. Both parties have signed this letter to confirm their agreement to these changes.
EX-4.6 2 exh4_6.htm EXHIBIT 4.6
Exhibit 4.6
Boston Therapeutics Inc.
1750 Elm Street
Manchester, NH 03104
March 17, 2016
CJY Holdings Limited
12 Repulse Bay Road
Repulse Bay, Hong Kong
| Re: | Securities Purchase Agreement dated September 24, 2015 (the “SPA”) by and between Boston Therapeutics Inc. and CJY Holdings Limited, as amended |
Gentlemen:
Reference is hereby made to the SPA. By executing this letter, the undersigned investor agrees that the offering amount shall be increased from $1,450,000 to $1,602,000. Accordingly, it is hereby agreed to by the parties that Section 1(d) of the Agreement shall be amended and restated to state the following:
"d. Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,602,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
We kindly request that you execute this letter below indicating that you agree with the above amendment.
| | Sincerely, Boston Therapeutics Inc. By: /s/ Conroy Chi-Heng Cheng Name: Conroy Chi-Heng Cheng Title: Interim CEO |
| | |
AGREED AND ACKNOWLEDGED:
CJY Holdings Limited
By: /s/ Cheng Chi Him
Name: Cheng Chi Him
Title:
